$APUS
Apimeds Pharmaceuticals US, Inc.
XASE•Health Care•Pharmaceutical Preparations
$1.77
▲+5.99%+$0.100
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateApimeds Pharmaceuticals US, Inc.
XASE•Health Care•Pharmaceutical Preparations
Why is APUS up today? It is at $1.77 (+5.99%), and our scanner flagged it 9 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment APUS spikes, and full due diligence on APUS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $APUS 9 times in the last 30 days. Create a free account to track $APUS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on APUS from our scanner (live price and day move above). A recent catalyst in the news: “IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc..”
Likely catalystMaterial Agreement · Executive / Board Change, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on APUS from our scanner (live price and day move above). A recent catalyst in the news: “IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc..”
APUS last traded at $1.77, up 5.99% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Apimeds Pharmaceuticals US, Inc. (APUS) is next expected to report earnings on Wednesday, November 11, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The APUS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged APUS 9 times in the last 30 days.
APUS (Apimeds Pharmaceuticals US, Inc.) trades on XASE, with a market cap of about $3M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge APUS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$APUS discussion
Sign in to ask a question or join the discussion.